ALFA Finder| Revenue growth | 55% YoY in Q4; 71% YoY for full FY26. |
|---|---|
| Margins | EBITDA margin at 36% for Q4; 44% for full FY26. |
| Demand visibility | High visibility from rising Ayurvedic awareness and 100+ city presence. |
| Management confidence | Strong momentum cited across both healthcare services and product verticals. |
Growth
Q4FY26 Revenue grew 55% YoY to ₹215.55 Cr; PAT increased 79% YoY to ₹45.35 Cr. FY26 EBITDA margin hit 44%.
Outlook
Final dividend of ₹4.50 recommended. Focus on 2,861 bed capacity expansion and the new Health Card loyalty program.
Risks
Sequential margin moderation due to labor code provisioning, ESOPs, and performance bonuses.
Earnings Call filed with BSE, NSE: JSLL. Summary written with AI assistance from the document.
Jeena Sikho Lifecare Ltd: key numbers
- Share price
- ₹367.95
- Market cap
- ₹4,575 Cr
- Revenue (annual)
- ₹801.4 Cr
- Net profit (annual)
- ₹221.8 Cr
- P/E (TTM)
- 19.3×Sector 43.8×
- Promoter holding
- 63.67%+0.05% QoQ
- FII holding
- 4.49%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jeena Sikho Lifecare Ltd
All →Jeena Sikho Lifecare Product Launch
Jeena Sikho Lifecare launched ten new Ayurvedic healthcare products in the domestic market on November 11, 2026. The filing gives product-wise details under SEBI product-launch disclosure rules.
Jeena Sikho Lifecare Merger & Restructuring Worth ₹0.03 Cr
Jeena Sikho Lifecare's board approved incorporating Ayugenomics Private Limited as a subsidiary, holding 60%. The company will invest Rs 3 lakh, subject to statutory approvals.
- Value
- ₹0.03 Cr
Jeena Sikho Lifecare Board Meeting Date
Jeena Sikho Lifecare has scheduled a board meeting for 14 Nov 2026 to consider unaudited Q1 FY27 financial results. The trading window is closed from 1 Oct to 16 Nov 2026.
Jeena Sikho Lifecare Other Announcement
Jeena Sikho Lifecare Ltd filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as per regulatory requirements.
Jeena Sikho Lifecare Employee Stock Options
Jeena Sikho Lifecare allotted 23,374 equity shares under its ESOS 2024 scheme. This allotment increases the company's total paid-up equity share capital.
Jeena Sikho Lifecare Product Launch
Jeena Sikho Lifecare Limited has launched eight new Ayurvedic healthcare, wellness, and nutraceutical products. These new offerings are now available in the domestic market.